Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer

CONCLUSION: TD resulting from PD-1/PD-L1 inhibitor treatment in advanced lung cancer may be associated with good clinical outcomes. The clarification of the molecular mechanisms underlying TD and the identification of reliable predictive biomarkers will guide clinicians in managing TD in this patient …